Life and Death after ICD Implantation  

Oleh:

Healey, Jeff ; Connolly, Stuart

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 359 no. 10 (Sep. 2008), page 1058.
Fulltext: (1058)359 no.10.pdf (79.72KB)

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.05 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Randomized trials have established that the prophylactic use of implantable cardioverter–defibrillators (ICDs) prolongs survival in patients with left ventricular dysfunction that is due to myocardial infarction1 or associated with heart failure from any cause.2 One of the pivotal trials, the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) (ClinicalTrials.gov number, NCT00000609 [ClinicalTrials.gov] ), compared ICD therapy or amiodarone with placebo in 2521 patients with symptomatic heart failure due to ischemic or nonischemic left ventricular dysfunction.2 That trial showed that among patients who had an ICD as compared with those who received a placebo, there was an absolute reduction in mortality of . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali